Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 4
2018 3
2021 3
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Oxidative phosphorylation in bone cells.
Sabini E, Arboit L, Khan MP, Lanzolla G, Schipani E. Sabini E, et al. Bone Rep. 2023 May 23;18:101688. doi: 10.1016/j.bonr.2023.101688. eCollection 2023 Jun. Bone Rep. 2023. PMID: 37275785 Free PMC article.
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini A, Torregrossa L, Basolo F, Vitti P, Elisei R. Molinaro E, et al. Among authors: sabini e. Nat Rev Endocrinol. 2017 Nov;13(11):644-660. doi: 10.1038/nrendo.2017.76. Epub 2017 Jul 14. Nat Rev Endocrinol. 2017. PMID: 28707679 Review.
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.
Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L, Giani C, Sabini E, Passannati P, Puleo L, Matrone A, Pontillo-Contillo B, Battaglia V, Mazzeo S, Vitti P, Elisei R. Viola D, et al. Among authors: sabini e. Endocr Relat Cancer. 2016 Apr;23(4):R185-205. doi: 10.1530/ERC-15-0555. Endocr Relat Cancer. 2016. PMID: 27207700 Review.
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer.
Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R. Lorusso L, et al. Among authors: sabini e. Onco Targets Ther. 2016 Oct 20;9:6467-6477. doi: 10.2147/OTT.S84625. eCollection 2016. Onco Targets Ther. 2016. PMID: 27799794 Free PMC article. Review.
Natural history of graves' orbitopathy after treatment.
Menconi F, Leo M, Sabini E, Mautone T, Nardi M, Sainato A, Sellari-Franceschini S, Vitti P, Marcocci C, Marinò M. Menconi F, et al. Among authors: sabini e. Endocrine. 2017 Aug;57(2):226-233. doi: 10.1007/s12020-016-1136-x. Epub 2016 Oct 5. Endocrine. 2017. PMID: 27709471
Osteoblastic erythropoietin is not required for bone mass accrual.
Lanzolla G, Merceron C, Khan MP, Sabini E, Giaccia A, Schipani E. Lanzolla G, et al. Among authors: sabini e. JBMR Plus. 2024 Apr 15;8(6):ziae052. doi: 10.1093/jbmrpl/ziae052. eCollection 2024 Jun. JBMR Plus. 2024. PMID: 38764792 Free PMC article.
19 results